ArticleBMC cancer2011

Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.

Nelma Pértega-Gomes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.